Compare SMTI & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTI | INGN |
|---|---|---|
| Founded | 1982 | 2001 |
| Country | United States | United States |
| Employees | N/A | 753 |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.5M | 136.1M |
| IPO Year | 2008 | 2013 |
| Metric | SMTI | INGN |
|---|---|---|
| Price | $35.10 | $5.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $34.00 | $11.25 |
| AVG Volume (30 Days) | 208.4K | ★ 285.1K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | $15,586,976.00 | ★ $348,668,000.00 |
| Revenue This Year | $17.31 | $8.03 |
| Revenue Next Year | $12.48 | $7.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.47 | 3.86 |
| 52 Week Low | $16.05 | $5.05 |
| 52 Week High | $35.34 | $9.13 |
| Indicator | SMTI | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 69.28 | 34.36 |
| Support Level | $33.99 | N/A |
| Resistance Level | N/A | $6.73 |
| Average True Range (ATR) | 0.23 | 0.15 |
| MACD | -0.18 | 0.02 |
| Stochastic Oscillator | 65.28 | 11.11 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.